| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/05/2005 | CN1560080A Corpuscles of stannius protein, stanniocalcin |
| 01/05/2005 | CN1560078A Tumor antigen based on products of the tumor suppressor gene WT1 |
| 01/05/2005 | CN1560077A Immunogen of cycloproply thaastral and preparation process thereof |
| 01/05/2005 | CN1560076A Derivant with reducing calcium gene related peptide and preparation process thereof |
| 01/05/2005 | CN1560075A Synthesis process for analogue 2R-515 of juvenile hormone |
| 01/05/2005 | CN1183251C Method for recoverying recombinant HBsAg |
| 01/05/2005 | CN1183249C Frozen food product |
| 01/05/2005 | CN1183246C Extracellent expression of cellulose binding domains (CBD) using bacillus |
| 01/05/2005 | CN1183158C Exendin analogue, processes for their preparation and medicaments containing them |
| 01/05/2005 | CN1183157C Method for distillig active protein liquid of scorpion |
| 01/05/2005 | CN1183155C Peptide useful as ligand |
| 01/05/2005 | CN1183112C PEG-inerferon conjugate |
| 01/05/2005 | CN1182879C Stabilized mixture comprising fibrinogen |
| 01/05/2005 | CN1182874C Gene therapy for diabetic ischemic disease |
| 01/05/2005 | CN1182870C Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations |
| 01/05/2005 | CN1182868C Mutent enterotoxin effective as non-toxic oral adjuvant |
| 01/04/2005 | US6838593 Austin responsive promoter sequences and methods of using the same |
| 01/04/2005 | US6838592 Using modulators of endocytic activity to treat neuodegenerative diseases |
| 01/04/2005 | US6838556 Promoters for regulated gene expression |
| 01/04/2005 | US6838554 Nucleic acids encoding proteins that stimulate the proliferation of t-lymphocytes |
| 01/04/2005 | US6838553 Peptide repeat immunogens |
| 01/04/2005 | US6838552 Diagnosis and management of infection caused by Chlamydia |
| 01/04/2005 | US6838551 Protein AMSH and cDNA thereof |
| 01/04/2005 | US6838550 Suppressors of death domains |
| 01/04/2005 | US6838549 For treatment of leukemia; enhancing bone marrow recovery in allogeneic or autologous transplantation and in treatment, radiation, chemically, or chemotherapeutically induced aplasia or myelosuppression |
| 01/04/2005 | US6838548 Artiodactyl epimorphine |
| 01/04/2005 | US6838446 Anticancer agents; genetic engineered enzyme |
| 01/04/2005 | US6838445 Tumor antigen peptide originating in SART-1 |
| 01/04/2005 | US6838444 Using nucleic acid; repair interior ear hair |
| 01/04/2005 | US6838438 Motilin Homologs |
| 01/04/2005 | US6838437 Inactivation resistant factor VIII |
| 01/04/2005 | US6838435 Grampositive, gramnegative bacteria; bactericides, fungicides; antibiotic resistance |
| 01/04/2005 | US6838433 Peptides used as inhibitors of interleukin-6 (IL-6), for prophylaxis, therapy and/or diagnosis of blood disorders such as leukemia |
| 01/04/2005 | US6838431 Nutritional intervention composition containing a source of proteinase inhibitor extending post meal satiety |
| 01/04/2005 | US6838428 A non-human mammal phenotype, vectors expressing the protein for treating respiratory system disease, viral diseases, purifying SP-D antibodies, enzyme inhibitor of metalloproteinase |
| 01/04/2005 | US6838290 Detecting modulators of interleukin activity; obtain modulator, incubate with preferential cells, monitor interleukin response |
| 01/04/2005 | US6838282 Polynucleotide that encodes a polypeptide; binding specificity; useful in bone marrow transplantation and gene therapy |
| 01/04/2005 | US6838279 DNA having a deletion in both copies of the LAT gene and ICP34.5 gene are inserted into the malignant cell |
| 01/04/2005 | US6838275 Human G-coupled protein receptor kinases and polynucleotides encoding the same |
| 01/04/2005 | US6838274 Urocortin proteins and uses thereof |
| 01/04/2005 | US6838273 Cloning and characterization of the FLBA gene of H. pylori, production of aflagellate strains |
| 01/04/2005 | US6838270 Gene encoding protein capable of regenerating luciferin, novel recombinant DNA, and process for producing protein capable of regenerating luciferin |
| 01/04/2005 | US6838267 Nucleotide sequences coding polypeptide associate with generating amino acids for use in human medicines, pharmacetucals, foods and animal nutrition |
| 01/04/2005 | US6838264 Antigenic peptide for inducing the formation of antibodies |
| 01/04/2005 | US6838263 Fusion protein for use as diagnostic tool in genetic engineering |
| 01/04/2005 | US6838262 Isolated DNA molecule encoding rank ligand |
| 01/04/2005 | US6838260 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 01/04/2005 | US6838259 Process for producing kiss-1 peptide |
| 01/04/2005 | US6838258 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 01/04/2005 | US6838256 Coding sequences of the human BRCA1 gene |
| 01/04/2005 | US6838241 Protein transport-associated molecules |
| 01/04/2005 | US6838237 Antigenically reactive regions of the hepatitis a virus polyprotein |
| 01/04/2005 | US6838236 Comprises human immunodeficiency virus viral protein r (VPR) for treating and preventing cancer and viral diseases |
| 01/04/2005 | US6838113 Increasing the digestibility of food proteins by thioredoxin reduction |
| 01/04/2005 | US6838085 DNA immunization against Chlamydia infection |
| 01/04/2005 | US6838084 For connection with major histomcompatability complex molecules |
| 01/04/2005 | US6838079 Methods for using the obese product to stimulate hematopoietic development |
| 01/04/2005 | US6838076 Pulmonary administration of chemically modified insulin |
| 01/04/2005 | CA2288341C Erythropoietin in the treatment of domestic and livestock animals for anemia |
| 01/04/2005 | CA2285023C High avidity polyvalent and polyspecific reagents |
| 01/04/2005 | CA2274982C New escherichia coli host/vector system based on antibiotic-free selection by complementation of an auxotrophy |
| 01/04/2005 | CA2213577C A process for the preparation of factor ix from biological sources |
| 12/30/2004 | US20040268440 Transgenic plants expressing cobalamin binding proteins |
| 12/30/2004 | US20040268435 Cotton transcription factors and their uses |
| 12/30/2004 | US20040268433 Methods and means for modulating cellulose biosynthesis in fiber producing plants |
| 12/30/2004 | US20040268426 P2Y4 receptor transgenic and knockout non-human mammals |
| 12/30/2004 | US20040268423 inhibiting formation of neurofibrillary tangles by reducing formation of a carboxyl-terminal truncated form of apolipoprotein E (apoE) in a neuron in the individual; animal models of Alzheimer's disease (AD); treating AD; drug screening |
| 12/30/2004 | US20040267004 nucleic acid that binds to high mobility group protein-I (HMG-I), and causes presenilin-2 gene exon 5-lacked type aberrant splicing by the association with the HMG-I protein; an inhibitor for inhibiting a binding between protein-nucleic acid caused by aberrant splicing; drug screening; antisense agents |
| 12/30/2004 | US20040267003 Nucleotide and amino aicd sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 12/30/2004 | US20040267000 Atherosclerosis susceptibility gene locus 1(athsq1) and atherosclerosis susceptibility gene locus 2 (athsq2) |
| 12/30/2004 | US20040266994 Type-1 ribosome-inactivating protein |
| 12/30/2004 | US20040266993 Therapeutic fusion protein comprising variable region complementarity determining regions which exhibit similar or better binding characteristics as monoclonal antibodies; immunotherapy and treatment of metabolic disorders |
| 12/30/2004 | US20040266990 Cd109 nucleic acid molecules polypeptides and methods of use |
| 12/30/2004 | US20040266989 Methods and compositions for the treatment of gastrointestinal disorders |
| 12/30/2004 | US20040266988 Macrocyclic peptidomimetic for use in treatment of multiple sclerosis and autoimmune disorders |
| 12/30/2004 | US20040266987 Attenuated flavivrus strains containing a mutated m-ectodomain and their applications |
| 12/30/2004 | US20040266797 Use of potent,selective and non toxic c-kit inhibitors for treating tumor angiogensis |
| 12/30/2004 | US20040266771 Use of tyrosine kinase inhibitors for treating bone loss |
| 12/30/2004 | US20040266715 Neurite regeneration |
| 12/30/2004 | US20040266713 Using nucleic acids; antitumor agents |
| 12/30/2004 | US20040266711 Gene for efficiency biosynthesis; prevent food spoilage; milk from trabsgenic animal |
| 12/30/2004 | US20040266694 Angiogenesis inhibitor induced by vascular endothelial growth factor |
| 12/30/2004 | US20040266693 Antibody for diagnosising immunology disorders |
| 12/30/2004 | US20040266692 Gastrointestinal disorders |
| 12/30/2004 | US20040266691 for promoting the survival, growth, proliferation, or maintenance of neurons in an injured but not severed spinal cord; promoting axonal regeneration, inhibiting the effects of scar tissue formation |
| 12/30/2004 | US20040266687 Antiproliferative agents; antiinflammatory agents; angiogenesis inhibitors; anticancer agents |
| 12/30/2004 | US20040266686 Administering endothelial growth factor antagonist; wound healing agents |
| 12/30/2004 | US20040266684 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 12/30/2004 | US20040266682 administering gastrin/(cholecystokinin (CCK) receptor ligand and a factor for complementing gastrin for islet neogenesis therapy; sustained release; for expanding a functional beta cell mass of pancreatic islet transplants; reduces amount of stem cells necessary for treatment; kits |
| 12/30/2004 | US20040266675 Transgenic aniomal nmodels; screening; administering peptide |
| 12/30/2004 | US20040266674 For diagnosis, therapy, prevention of cell proliferation, autoimmune disease, antiinflammatory agents, cardiovascular disorders, central nervous system disorders; isolated nucleic acids; genetic engineeringo |
| 12/30/2004 | US20040266673 Cardiovascular disorders; congestive heart failure |
| 12/30/2004 | US20040266671 Orally administered peptides synergize statin activity |
| 12/30/2004 | US20040266665 Therapy for thyroid disease; anticancer agents; metabolitic and reproductive diseases |
| 12/30/2004 | US20040266010 Modifying fatty acid content of bacterial cells to enhance gene transferability after long term storage at low temperatures |
| 12/30/2004 | US20040266006 Adenoviral vectors having a protein IX deletion |
| 12/30/2004 | US20040265982 Peptide or mimetic which enhances cholesterol ester hydrolase activity for use in identifying modulators for treatment and prevention of cardiovascular disorders |
| 12/30/2004 | US20040265981 A cDna clone; culturing liver cell in coditioning media |
| 12/30/2004 | US20040265976 Antigen and lysine acylated protein; cytokines; drug screening; liquid chromatography |
| 12/30/2004 | US20040265975 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence |